580 related articles for article (PubMed ID: 22773138)
1. Tauroursodeoxycholic acid prevents MPTP-induced dopaminergic cell death in a mouse model of Parkinson's disease.
Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson CJ; Wolf CR; Rodrigues CM; Gama MJ
Mol Neurobiol; 2012 Oct; 46(2):475-86. PubMed ID: 22773138
[TBL] [Abstract][Full Text] [Related]
2. Glutathione S-transferase pi mediates MPTP-induced c-Jun N-terminal kinase activation in the nigrostriatal pathway.
Castro-Caldas M; Carvalho AN; Rodrigues E; Henderson C; Wolf CR; Gama MJ
Mol Neurobiol; 2012 Jun; 45(3):466-77. PubMed ID: 22539231
[TBL] [Abstract][Full Text] [Related]
3. Tauroursodeoxycholic Acid Improves Motor Symptoms in a Mouse Model of Parkinson's Disease.
Rosa AI; Duarte-Silva S; Silva-Fernandes A; Nunes MJ; Carvalho AN; Rodrigues E; Gama MJ; Rodrigues CMP; Maciel P; Castro-Caldas M
Mol Neurobiol; 2018 Dec; 55(12):9139-9155. PubMed ID: 29651747
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 activation by tauroursodeoxycholic acid in experimental models of Parkinson's disease.
Moreira S; Fonseca I; Nunes MJ; Rosa A; Lemos L; Rodrigues E; Carvalho AN; Outeiro TF; Rodrigues CMP; Gama MJ; Castro-Caldas M
Exp Neurol; 2017 Sep; 295():77-87. PubMed ID: 28552716
[TBL] [Abstract][Full Text] [Related]
5. Neurotoxic effects of MPTP on mouse cerebral cortex: Modulation of neuroinflammation as a neuroprotective strategy.
Mendes MO; Rosa AI; Carvalho AN; Nunes MJ; Dionísio P; Rodrigues E; Costa D; Duarte-Silva S; Maciel P; Rodrigues CMP; Gama MJ; Castro-Caldas M
Mol Cell Neurosci; 2019 Apr; 96():1-9. PubMed ID: 30771505
[TBL] [Abstract][Full Text] [Related]
6. Tauroursodeoxycholic acid (TUDCA) is neuroprotective in a chronic mouse model of Parkinson's disease.
Cuevas E; Burks S; Raymick J; Robinson B; Gómez-Crisóstomo NP; Escudero-Lourdes C; Lopez AGG; Chigurupati S; Hanig J; Ferguson SA; Sarkar S
Nutr Neurosci; 2022 Jul; 25(7):1374-1391. PubMed ID: 33345721
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside in the MPTP-induced mouse model of Parkinson's disease: Involvement of reactive oxygen species-mediated JNK, P38 and mitochondrial pathways.
He H; Wang S; Tian J; Chen L; Zhang W; Zhao J; Tang H; Zhang X; Chen J
Eur J Pharmacol; 2015 Nov; 767():175-82. PubMed ID: 26477638
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of the gliopeptide ODN in an in vivo model of Parkinson's disease.
Bahdoudi S; Ghouili I; Hmiden M; do Rego JL; Lefranc B; Leprince J; Chuquet J; do Rego JC; Marcher AB; Mandrup S; Vaudry H; Tonon MC; Amri M; Masmoudi-Kouki O; Vaudry D
Cell Mol Life Sci; 2018 Jun; 75(11):2075-2091. PubMed ID: 29264673
[TBL] [Abstract][Full Text] [Related]
10. Shikonin ameliorates oxidative stress and neuroinflammation via the Akt/ERK/JNK/NF-κB signalling pathways in a model of Parkinson's disease.
Guo L; Li Y; Li W; Qiu J; Du J; Wang L; Zhang T
Clin Exp Pharmacol Physiol; 2022 Nov; 49(11):1221-1231. PubMed ID: 36054693
[TBL] [Abstract][Full Text] [Related]
11. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
[TBL] [Abstract][Full Text] [Related]
12. Vitexin protects dopaminergic neurons in MPTP-induced Parkinson's disease through PI3K/Akt signaling pathway.
Hu M; Li F; Wang W
Drug Des Devel Ther; 2018; 12():565-573. PubMed ID: 29588573
[TBL] [Abstract][Full Text] [Related]
13. Activation of apoptosis signal regulating kinase 1 (ASK1) and translocation of death-associated protein, Daxx, in substantia nigra pars compacta in a mouse model of Parkinson's disease: protection by alpha-lipoic acid.
Karunakaran S; Diwakar L; Saeed U; Agarwal V; Ramakrishnan S; Iyengar S; Ravindranath V
FASEB J; 2007 Jul; 21(9):2226-36. PubMed ID: 17369508
[TBL] [Abstract][Full Text] [Related]
14. Teaghrelin protected dopaminergic neurons in MPTP-induced Parkinson's disease animal model by promoting PINK1/Parkin-mediated mitophagy and AMPK/SIRT1/PGC1-α-mediated mitochondrial biogenesis.
Jhuo CF; Chen CJ; Tzen JTC; Chen WY
Environ Toxicol; 2024 Jul; 39(7):4022-4034. PubMed ID: 38622810
[TBL] [Abstract][Full Text] [Related]
15. Neuroprotective Effect of Chlorogenic Acid on Mitochondrial Dysfunction-Mediated Apoptotic Death of DA Neurons in a Parkinsonian Mouse Model.
Singh SS; Rai SN; Birla H; Zahra W; Rathore AS; Dilnashin H; Singh R; Singh SP
Oxid Med Cell Longev; 2020; 2020():6571484. PubMed ID: 32566093
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effects of puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease model in mice.
Zhu G; Wang X; Wu S; Li X; Li Q
Phytother Res; 2014 Feb; 28(2):179-86. PubMed ID: 23512787
[TBL] [Abstract][Full Text] [Related]
17. JNK inhibitor protects dopaminergic neurons by reducing COX-2 expression in the MPTP mouse model of subacute Parkinson's disease.
Wang Y; Zhang Y; Wei Z; Li H; Zhou H; Zhang Z; Zhang Z
J Neurol Sci; 2009 Oct; 285(1-2):172-7. PubMed ID: 19604516
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective properties of icariin in MPTP-induced mouse model of Parkinson's disease: Involvement of PI3K/Akt and MEK/ERK signaling pathways.
Chen WF; Wu L; Du ZR; Chen L; Xu AL; Chen XH; Teng JJ; Wong MS
Phytomedicine; 2017 Feb; 25():93-99. PubMed ID: 28190476
[TBL] [Abstract][Full Text] [Related]
19. Deferoxamine-mediated up-regulation of HIF-1α prevents dopaminergic neuronal death via the activation of MAPK family proteins in MPTP-treated mice.
Guo C; Hao LJ; Yang ZH; Chai R; Zhang S; Gu Y; Gao HL; Zhong ML; Wang T; Li JY; Wang ZY
Exp Neurol; 2016 Jun; 280():13-23. PubMed ID: 26996132
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]